Singapore pharma firm debuts on Korean main bourse

Uploaded By:  Paul Howell Submitted By:  Staff Reporter Case Study:  No The firm develops biosimilars, new antibody therapeutics. Singapore-based biopharmaceutical company Prestige BioPharma has become the first Singapore company to be listed on the Korea Exchange (KOSPI). The firm focuses on developing biosimilars and new antibody therapeutics. According to reports, Prestige BioPharma has debuted on the KOSPI due to its business relations with Prestige Biologics, a biologics contract development manufacturing organisation that would manufacture the firm’s core products and has facilities in Korea. read more